BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 20225045)

  • 1. The RNA silencing technology applied by lentiviral vectors in oncology.
    Sumimoto H; Kawakami Y
    Methods Mol Biol; 2010; 614():187-99. PubMed ID: 20225045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and cloning of lentiviral vectors expressing small interfering RNAs.
    Tiscornia G; Singer O; Verma IM
    Nat Protoc; 2006; 1(1):234-40. PubMed ID: 17406238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction of a lentiviral vector for RNA interference of human CDH22 gene and its gene silencing effect in SW480 cells].
    Zhou J; Li JM; Yang FD; Liu YH; Ding YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):589-92. PubMed ID: 18495598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral vector delivery of recombinant small interfering RNA expression cassettes.
    Li MJ; Rossi JJ
    Methods Enzymol; 2005; 392():218-26. PubMed ID: 15644184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y; Nishikawa M; Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
    ter Brake O; Berkhout B
    J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells.
    Arrighi JF; Pion M; Wiznerowicz M; Geijtenbeek TB; Garcia E; Abraham S; Leuba F; Dutoit V; Ducrey-Rundquist O; van Kooyk Y; Trono D; Piguet V
    J Virol; 2004 Oct; 78(20):10848-55. PubMed ID: 15452205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of RNAi library to oncology investigation].
    Weng DH; Wang SX; Ma D
    Ai Zheng; 2008 Nov; 27(11):1229-32. PubMed ID: 19000460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The construction of lentivirus-mediated RNAi vector containing hTERT].
    Zhao P; Fu Z; You YP; Wang CZ; Cheng YX; Lu XM; Lu A; Liu N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):27-31. PubMed ID: 18247299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.
    Dreyer JL
    Methods Mol Biol; 2010; 614():3-35. PubMed ID: 20225033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of interferon-stimulated gene induction by RNAi vectors.
    Pebernard S; Iggo RD
    Differentiation; 2004 Mar; 72(2-3):103-11. PubMed ID: 15066190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of knockdown rats by lentiviral transduction of embryos with short hairpin RNA transgenes.
    Dann CT; Garbers DL
    Methods Mol Biol; 2008; 450():193-209. PubMed ID: 18370061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
    Chang LJ; Liu X; He J
    Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
    ter Brake O; Konstantinova P; Ceylan M; Berkhout B
    Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral vector delivery of siRNA and shRNA encoding genes into cultured and primary hematopoietic cells.
    Li M; Rossi JJ
    Methods Mol Biol; 2005; 309():261-72. PubMed ID: 15990406
    [No Abstract]   [Full Text] [Related]  

  • 16. [Establishment of a stable nasopharyngeal carcinoma cell line with lentivirus-mediated RNA interference for EIF4G1 gene silencing].
    Tu LX; Fang WY; Liu Z; Li X; He Y; Xie SM; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):844-7, 851. PubMed ID: 19460689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbance of the microRNA pathway by commonly used lentiviral shRNA libraries limits the application for screening host factors involved in hepatitis C virus infection.
    Pan Q; de Ruiter PE; von Eije KJ; Smits R; Kwekkeboom J; Tilanus HW; Berkhout B; Janssen HL; van der Laan LJ
    FEBS Lett; 2011 Apr; 585(7):1025-30. PubMed ID: 21376045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of RNA interference against cancer.
    Takeshita F; Ochiya T
    Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentiviral vector-mediated RNAi and its use for cancer research.
    Sumimoto H; Kawakami Y
    Future Oncol; 2007 Dec; 3(6):655-64. PubMed ID: 18041918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knock-down of gene expression in hematopoietic cells.
    Scherr M; Venturini L; Eder M
    Methods Mol Biol; 2009; 506():207-19. PubMed ID: 19110629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.